Helmholtz Gemeinschaft


Metaproteomics approach and pathway modulation in obesity and diabetes: a narrative review

[img] PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Item Type:Review
Title:Metaproteomics approach and pathway modulation in obesity and diabetes: a narrative review
Creators Name:Calabrese, F.M. and Porrelli, A. and Vacca, M. and Comte, B. and Nimptsch, K. and Pinart, M. and Pischon, T. and Pujos-Guillot, E. and De Angelis, M.
Abstract:Low-grade inflammatory diseases revealed metabolic perturbations that have been linked to various phenotypes, including gut microbiota dysbiosis. In the last decade, metaproteomics has been used to investigate protein composition profiles at specific steps and in specific healthy/pathologic conditions. We applied a rigorous protocol that relied on PRISMA guidelines and filtering criteria to obtain an exhaustive study selection that finally resulted in a group of 10 studies, based on metaproteomics and that aim at investigating obesity and diabetes. This batch of studies was used to discuss specific microbial and human metaproteome alterations and metabolic patterns in subjects affected by diabetes (T1D and T2D) and obesity. We provided the main up- and down-regulated protein patterns in the inspected pathologies. Despite the available results, the evident paucity of metaproteomic data is to be considered as a limiting factor in drawing objective considerations. To date, ad hoc prepared metaproteomic databases collecting pathologic data and related metadata, together with standardized analysis protocols, are required to increase our knowledge on these widespread pathologies.
Keywords:Metaproteomics, Low-Grade Inflammation, Obesity, Diabetes, Gut Microbiota, Metabolic Diseases
Page Range:47
Date:January 2022
Official Publication:https://doi.org/10.3390/nu14010047
PubMed:View item in PubMed

Repository Staff Only: item control page


Downloads per month over past year

Open Access
MDC Library